Howard Kaufman

Howard L.
Kaufman currently works at Ankyra Therapeutics, Inc., as President, Chief Executive Officer & Director from 2022.
Dr. Kaufman also formerly worked at Rush University Medical Center, as Director-Cancer Center from 2009 to 2013, Rutgers Cancer Institute of New Jersey, as Chief Surgical Officer from 2014 to 2017, International Society for Biological Therapy of Cancer, as President from 2014 to 2016, and Replimune Group, Inc., as Chief Medical Officer from 2017 to 2019.
Dr. Kaufman received his doctorate degree in 1986 from Loyola University of Chicago.